๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Increased erythrocyte and protein binding of codeine in patients with sickle cell disease

โœ Scribed by Sumia S. Mohammed; Mary M. Christopher; Paulette Mehta; Amos Kedar; Samuel Gross; Hartmut Derendorf


Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
718 KB
Volume
82
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Malignancy in patients with sickle cell
โœ William H. Schultz; for the International Association of Sickle Cell Nurses; Phy ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 66 KB ๐Ÿ‘ 2 views
Post-transfusion alloimmunization in pat
โœ Armando R. Orlina; Phyllis J. Unger; Mabel Koshy ๐Ÿ“‚ Article ๐Ÿ“… 1978 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 339 KB ๐Ÿ‘ 2 views

The transfusion histories over a 33-month period of 50 patients with sickle cell disease were reviewed to determine the frequency of alloimmunization to red cell antigens following transfusion in these patients. There were 30 females and 20 males, aged 19--49 years. Eighteen (36%) were immunized of

Increased strength of erythrocyte aggreg
โœ Nitsan Maharshak; Yaron Arbel; Itzhak Shapira; Shlomo Berliner; Ronen Ben-Ami; S ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 259 KB

## Background: Increased strength of red blood cell (rbc) aggregates are present during the acute inflammatory response and contribute to erythrocyte aggregation and may lead to microvascular dysfunction. inflammatory bowel diseases (ibds) are characterized by damage to the bowel wall. this damage

Quantitative analysis of erythrocytes co
โœ Marcus, Stacy J.; Kinney, Thomas R.; Schultz, William H.; O'Branski, Erin E.; Wa ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 110 KB ๐Ÿ‘ 2 views

Variation in the level of fetal hemoglobin (HbF) accounts for much of the clinical heterogeneity observed in patients with sickle cell disease (SCD). The HbF level has emerged as an important prognostic factor in both sickle cell pain and mortality, and a % HbF of 10-20% has been suggested as a thre